| abstract |
Novel LPS having the following physical properties, novel bacilli providing those LPS, and novel immunity stimulators, analgesics, and antiwithdrawal agents, and novel veterinary immunity stimulators, analgesics, and antiwithdrawal agents containing LPS selected from the group consisting of those LPSs and mixtures thereof.LPS1Dominant molecular weight:5,000 ± 1,000 as determined by SDS-PAGE methodPhosphorus number:2 ± 1 / 5,000 (m.w.)Hexosamine number:9 ± 1 / 5,000 (m.w.)KDO number:2 ± 1 / 5,000 (m.w.)LPS2Dominant molecular weight:6,500 ± 2,500 as determined by SDS-PAGE methodPhosphorus number:1 to 2 / 5,000 (m.w.)Hexosamine number:7 ± 1 / 5,000 (m.w.)KDO number:1 to 2 / 5,000 (m.w.)LPS3Dominant molecular weight:6,500 ± 2,500 as determined by SDS-PAGE methodPhosphorus number:2 ± 1 / 5,000 (m.w.)Hexosamine number:5 ± 1 / 5,000 (m.w.)KDO number:2 ± 1 / 5,000 (m.w.) |